Washington University

Grantee Website St. Louis, Missouri, United States
Purpose
to determine whether triple drug therapy for lymphatic filariasis can be safely used in persons with onchocerciasis following a clearing dose of ivermectin
Division
Global Health
Year Awarded
2018
Region Served
GLOBAL,
AFRICA
Committed Amount
$2,653,723
Grant Topic
Neglected Tropical Diseases
Duration (Months)
59
Grantee Location
St. Louis, Missouri, United States

More about our work

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.